Among the 36 drugs from nine drug classes included for hypertension, α1-adrenergic receptor antagonists had the highest mean inflation-adjusted 28-day launch price (£36.50) followed by angiotensin converting enzyme (ACE) inhibitors (£35.00). The gene discussed is ACE; the disease is Hypertension.